Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 125 /hr
Hire Dr. Christopher R.
United Kingdom
USD 125 /hr
Freelance infectious disease scientist with 40+ years experience in academia, industry and healthcare sectors
Profile Summary
Subject Matter Expertise
Services
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
Work Experience
Visiting Lecturer
Middlesex University
October 2022 - Present
Visiting Lecturer
Middlesex University
October 2022 - Present 
Visiting Lecturer
University of Bedfordshire
October 2022 - April 2023
Visiting Lecturer
London South Bank University
October 2022 - April 2023
Senior Lecturer in Microbiology / Programme Leader
Middlesex University
September 2009 - September 2022
Senior Lecturer in Microbiology / Programme & Module Leader
Middlesex University
September 2009 - September 2022
Principal Scientist
Glaxo SmithKline
October 2001 - April 2009
Principal Scientist
GlaxoSmithKline
September 2001 - April 2009
Principal Scientist
Glaxo Wellcome
October 1999 - September 2001
Principal Scientist
Glaxo Wellcome
September 1999 - August 2001
Principal Scientist
Glaxo Wellcome
October 1996 - September 1999
Principal Scientist
Glaxo Wellcome
September 1996 - August 1999
Research Fellow
Cancer Research UK
October 1993 - September 1996
Research Fellow
University College London
September 1992 - August 1996
Graduate Research Assistant
University College London
October 1992 - September 1993
Graduate Research Assistant
University College London
October 1990 - September 1992
Research Assistant
University College London
September 1990 - August 1992
Research Assistant
Royal Postgraduate Medical School (now Imperial College)
October 1986 - September 1990
Research Assistant
Royal Postgraduate Medical School (now Imperial College London)
September 1986 - August 1990
Biomedical scientist
North Middlesex University Hospital
October 1981 - September 1985
Biomedical Scientist
North Middlesex Hospital
September 1981 - August 1985
Education
Postgraduate Certificate in Higher Education
Middlesex University
January 2010 - January 2011
Postgraduate Certificate in Higher Education (Natural Sciences)
Middlesex University
January 2010 - December 2010
PhD (Molecular Virology) (Virology)
University Of London
October 1986 - June 1991
PhD
University of London (Royal Postgraduate Medical School)
October 1986 - June 1991
MSc.
University of Reading
October 1985 - October 1986
MSc (Virology - Distinction)
University of Reading
October 1985 - September 1986
Special Examination in Virology
Institute of Biomedical Science
September 1983 - July 1985
Institute of Biomedical Science Special Examination in Virology
Paddington College (now University of Westminster)
September 1983 - June 1985
Business and Technicians Education Council Higher Certificate in Medical Laboratory Science specialising in Medical Microbiology
Harrow College of Higher Education (now University of Westminster)
September 1981 - July 1983
Higher Certificate in Medical Laboratory Science (specialising in Medical Microbiology)
Business and Technicians Education Council (BTEC)
September 1981 - July 1983
Certifications
Publications
BOOK CHAPTER
Christopher J.A. Ring, Edward D. Blair(2023). Introduction: viruses as vehicles and expressors of genetic material . Genetically Engineered Viruses. p. 1--4. Garland Science
Neil J. Clarke, John E. Bisi, Caretha L. Creasy, Michael K. Dush, Kris J. Fisher, John M. Johnson, Christopher J. A. Ring, Mark R. Edbrooke(2005). RNA interference technology in the discovery and validation of druggable targets . RNA Interference Technology. p. 347--360. Cambridge University Press
OTHER
Christopher Ring, Christiane Honisch, Vlad Serafim, Nicola Hennessy, David J. Allen, Leonardo P. Munoz, Saheer E. Gharbia, Ajit J. Shah, Haroun N. Shah(2017). Microbial DNA Analysis by MALDI‐TOF Mass Spectrometry . MALDI‐TOF and Tandem MS for Clinical Microbiology. p. 187--209. Wiley
JOURNAL ARTICLE
Serafim V, Ring C, Pantoja L, Shah H, Shah A(2017). Rapid Identification of E. coli Bacteriophages using Mass Spectrometry . Journal of Proteomics & Enzymology. 06. (01). {OMICS} Publishing Group
Vlad Serafim, Ajit Shah, Chris Ring, Haroun N Shah(2016). TRANSITION FROM MALDI-TOF-MS TO LC-MS/MS FOR IDENTIFICATION OF VIRUSES . Unpublished. Unpublished
C. Cazzin, L. Piccoli, M. Massagrande, N. Garbati, F. Michielin, H.-G. Knaus, C. J. A. Ring, A. D. Morrison, E. Merlo-Pich, Z. Rovo, et al.(2011). rKv1.2 overexpression in the central medial thalamic area decreases caffeine-induced arousal . Genes, Brain and Behavior. 10. (8). p. 817--827. Wiley
M. Kollarik, M. J. Carr, F. Ru, C. J. A. Ring, V. J. Hart, P. Murdock, A. C. Myers, Y. Muroi, B. J. Undem(2010). Transgene expression and effective gene silencing in vagal afferent neurons<i>in vivo</i>using recombinant adeno-associated virus vectors . The Journal of Physiology. 588. (21). p. 4303--4315. Wiley
Chiara Cazzin, Floriana Zanderigo, Vivian J.A. Costantini, Erika Zambello, Christopher J.A. Ring, Alastair D. Morrison, Laura Caberlotto, James N.C. Kew(2010). Adenoviral-mediated Cre expression effectively suppresses GlyT1 binding in the thalamic area of GlyT1 conditional knock-out mice . Journal of Neuroscience Methods. 193. (2). p. 254--263. Elsevier {BV}
Chiara Cazzin, Christopher J.A. Ring(2010). Recent advances in the manipulation of murine gene expression and its utility for the study of human neurological disease . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802. (10). p. 796--807. Elsevier {BV}
Miguel L Soares, Seiki Haraguchi, Maria-Elena Torres-Padilla, Tibor Kalmar, Lee Carpenter, Graham Bell, Alastair Morrison, Christopher JA Ring, Neil J Clarke, David M Glover, et al.(2005). Functional studies of signaling pathways in peri-implantation development of the mouse embryo by RNAi . BMC Developmental Biology. 5. (1). Springer Science and Business Media {LLC}
Caroline F. Maher, Tracy Hussell, Edward Blair, Christopher J.A. Ring, Peter J.M. Openshaw(2004). Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity . Microbes and Infection. 6. (12). p. 1049--1055. Elsevier {BV}
C Ward(2004). Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement . Journal of Clinical Virology. 29. (3). p. 179--188. Elsevier {BV}
TUOMO PUHAKKA, HEIKKI LEHTI, RAIJA VAINIONPÄÄ, VESA JORMANAINEN, MARKKU PULKKINEN, STEPHEN SHARP, CARON KERR, MARIA DEMPSEY, CHRISTOPHER JA RING, CHANTELLE WARD, et al.(2003). Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with Influenza . Scandinavian Journal of Infectious Diseases. 35. (1). p. 52--58. Informa {UK} Limited
Christopher J. A. Ring(2002). Cytolytic viruses as potential anti-cancer agents . Journal of General Virology. 83. (3). p. 491--502. Microbiology Society
CJA Ring, P Blouin, L-A Martin, HC Hurst, NR Lemoine(1997). Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme . Gene Therapy. 4. (10). p. 1045--1052. Springer Science and Business Media {LLC}
Ring CJ, Harris JD, Hurst HC, Lemoine NR (1996). Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. Gene therapy.
Pandha HS, Ring CJ, Sikora K (1996). Gene therapy for cancer. The New Zealand medical journal.
D. F.P. Larkin, H. B. Oral, C. J.A. Ring, N. R. Lemoine, A. J.T. George(1996). ADENOVIRUS-MEDIATED GENE DELIVERY TO THE CORNEAL ENDOTHELIUM1 . Transplantation. 61. (3). p. 363--370. Ovid Technologies (Wolters Kluwer Health)
Ali M, Lemoine NR, Ring CJ (1994). The use of DNA viruses as vectors for gene therapy. Gene therapy.
P J Morris, T Theil, C J Ring, K A Lillycrop, T Moroy, D S Latchman(1994). The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain . Molecular and Cellular Biology. 14. (10). p. 6907--6914. Informa {UK} Limited
C. J. A. Ring(1994). The B cell-immortalizing functions of Epstein-Barr virus . Journal of General Virology. 75. (1). p. 1--13. Microbiology Society
M Makris, JA Garson, CJ Ring, PW Tuke, RS Tedder, FE Preston(1993). Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients . Blood. 81. (7). p. 1898--1902. American Society of Hematology
N. S. Brink, R. Chopra, C. J. Perrons, C. J. A. Ring, J. A. Garson, E. M. Briggs, A. H. Goldstone, D. C. Linch, R. S. Tedder(1993). Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virological study . British Journal of Haematology. 83. (3). p. 498--503. Wiley
Peter J. Morris, Carolyn L. Dent, Christopher J. Ring, David S. Latchman(1993). The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells . Nucleic Acids Research. 21. (4). p. 1019--1023. Oxford University Press ({OUP})
C.J.A. Ring, D.S. Latchman(1993). The human Brn-3b POU transcription factor shows only limited homology to the Brn-3a/RDC-1 factor outside the conserved POU domain . Nucleic Acids Research. 21. (12). p. 2946--2946. Oxford University Press ({OUP})
Peter J. Morris, Christopher J.A. Ring, Karen A. Lillycrop, David S. Latchman(1993). Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains . Nucleic Acids Research. 21. (19). p. 4506--4510. Oxford University Press ({OUP})
C.J.A. Ring, D.S. Latchman(1993). The human Brn-3b POU transcription factor shows only limited homology to the Brn-3a/RDC-1 factor outside the conserved POU domain . Nucleic Acids Research. 21. (12). p. 2946--2946. Oxford University Press ({OUP})
C. J. A. Ring, M. D. Jones, B. E. Griffin(1992). Alternative Splicing Determines The Carboxy Terminus of the Epstein--Barr Virus Nuclear Antigen 5 Species Expressed in the Burkitt's Lymphoma Cell Line Daudi . Journal of General Virology. 73. (10). p. 2715--2719. Microbiology Society
J. A. Garson, A. N. Wicki, C. J. A. Ring, H. Joller, G. Zala, M. Schmid, H. Buehler(1992). Detection of hepatitis C viraemia in caucasian patients with hepatocellular carcinoma . Journal of Medical Virology. 38. (2). p. 152--156. Wiley
J. A. Garson, A. N. Wicki, C. J. A. Ring, H. Joller, G. Zala, M. Schmid, H. Buehler(1992). Detection of hepatitis C viraemia in caucasian patients with hepatocellular carcinoma . Journal of Medical Virology. 38. (2). p. 152--156. Wiley
J. A. Garson, S. Brillanti, C. Ring, P. Perini, M. Miglioli, L. Barbara(1992). Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis . Journal of Medical Virology. 37. (3). p. 210--214. Wiley
J. A. Garson, J. P. Clewley, P. Simmonds, L. Q. Zhang, J. Mori, C. Ring, E. A. C. Follett, B. C. Dow, S. Martin, H. Gunson(1992). Hepatitis C Viraemia in United Kingdom Blood Donors: A Multicentre Study . Vox Sanguinis. 62. (4). p. 218--223. Wiley
JeremyA. Garson, ChristopherJ.A. Ring, PhilipW. Tuke(1991). Improvement of HCV genome detection with "short" PCR products . The Lancet. 338. (8780). p. 1466--1467. Elsevier {BV}
R. S. Tedder, M. Briggs, C. Ring, P. W. Tuke, P. Jones, G. F. Savidge, B. Rodgers, J. A. Garson(1991). Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia . British Journal of Haematology. 79. (3). p. 512--515. Wiley
Christopher Ring, AwadA Saeed, AhmedM Al-Admawi, Abdulmohsin Al-Rasheed, Debbie Fairclough, Robby Bacchus, Jeremy Garson(1991). Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh . The Lancet. 338. (8764). p. 459--460. Elsevier {BV}
J. A. Garson, M. Lenzi, C. Ring, F. Cassani, G. Ballardini, M. Briggs, R. S. Tedder, F. B. Bianchi(1991). Hepatitis C viraemia in adults with type 2 autoimmune hepatitis . Journal of Medical Virology. 34. (4). p. 223--226. Wiley
S. Brillanti, J. A. Garson, P. W. Tuke, C. Ring, M. Briggs, C. Masci, M. Miglioli, L. Barbara, R. S. Tedder(1991). Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study . Journal of Medical Virology. 34. (2). p. 136--141. Wiley
S. Brillanti, J.A. Garson, P.W. Take, C. Masci, C. Ring, M. Briggs, M. Miglioli, R.S. Tedder, L. Barbara(1991). Antiviral effect of alpha interferon treatment in chronic hepatitis C: A quantitative PCR study . Journal of Hepatology. 13. p. S102. Elsevier {BV}
J.A Garson, C Ring, P Tuke, R.S Tedder(1990). Enhanced detection by PCR of hepatitis C virus RNA . The Lancet. 336. (8719). p. 878--879. Elsevier {BV}
J GARSON(1990). Detection by PCR of hepatitis C virus in factor VIII concentrates . The Lancet. 335. (8703). p. 1473. Elsevier {BV}
Ratings and Comments
Total Projects Awarded:
Comments: